In Brief: FDA Plaque Products subcommittee meeting
This article was originally published in The Rose Sheet
FDA Plaque Products subcommittee meeting: Proposed agenda for FDA's June 6-7 Dental Products Panel's Plaque Products Subcommittee includes the continuation of the safety and efficacy review of the ingredient combination sodium bicarbonate and hydrogen peroxide, and the botanical sanguinaria extract. At its December meeting, members of the subcommittee concluded that further data was needed to determine efficacy of sodium bicarbonate and hydrogen peroxide and that the efficacy data for sanguinaria was inconclusive. Chesebrough-Pond's and Church & Dwight market hydrogen peroxide/baking sodium toothpastes under the Mentadent and Arm & Hammer brands, respectively, while Colgate Palmolive manufactures Viadent with sanguinaria. Colgate and Chese-Pond's both received FDA warning letters for the antiplaque/antigingivitis marketing of their respective products ("The Rose Sheet" March 18, p. 4). The panel will also begin discussing the safety and efficacy of sodium lauryl sulfate, an ingredient found in Chese-Pond's Close-Up Anti-Plaque rinse...
You may also be interested in...
With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program
Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle
Weekly Trademark Review